Platelet Gene Therapy Promotes Targeted Peripheral Tolerance by Clonal Deletion and Induction of Antigen-Specific Regulatory T Cells
Xiaofeng Luo(Fujian Medical University), Qizhen Shi(Children's Hospital of Wisconsin), Calvin B. Williams(Medical College of Wisconsin), Subramaniam Malarkannan(Medical College of Wisconsin), Jianda Hu(Fujian Medical University), Jocelyn A. Schroeder(Medical College of Wisconsin), Juan Chen(Union Hospital), Christina K. Baumgartner(AbbVie (United States)), Kenneth P. Allen(Medical College of Wisconsin)
Cited by 15
Related Papers
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial
|The Lancet Haematology|2019|248
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|Cancer Cell|2020|234
Generation and Function of Induced Regulatory T Cells
|Frontiers in Immunology|2013|217
Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies
|Journal of Clinical Investigation|2006|188